Answers are grounded in this paper and cite their sources.
A 24-year-old, blind male with congenitally-corrected transposition of the great arteries and systemic right ventricular failure presented with New York Heart Association class IV heart failure despite home inotropic therapy. He was not a transplant candidate due to psychosocial issues. He underwent a successful HeartMate 3 (Abbott Laboratories) placement with the implementation of techniques to guide home ventricular assist device care despite blindness.
No takes yet. Share an insight, caveat, or question.
Ramchandani et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: